Arrowhead Research | ARWR - Eps Gewinn Pro Aktie

Aktienkurs
72.87
Täglich Wechseln
2.34 3.32%
Monatlich
16.22%
Jährlich
419.02%
Q2 Prognose
72.33

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q2 Mar/2026 -1.04 2.75 May/07
FY2026Q1 Dec/2025 0.22 0.04 -1.39 Feb/05
FY2025Q4 Sep/2025 -0.11 -0.23 -1.36 Nov/25
FY2025Q3 Jun/2025 -1.26 -0.86 -1.38 Aug/07
FY2025Q2 Mar/2025 2.75 -0.11 -1.02 May/12




Eps Veränderung Datum
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Incyte USD 1.81 0.01 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
Merck USD -1.28 3.32 2026-03
Moderna USD -2.11 1.6 2025-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Novartis USD 1.99 0.04 2026-03
Sarepta Therapeutics USD -3.58 3.45 2025-12
TG Therapeutics USD 0.14 2.29 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xencor USD -0.09 0.01 2025-12